Bridgebio Pharma shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Bridgebio Pharma
Tip: Access up to 7 years of quarterly data
All positions including Bridgebio Pharma held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bridgebio Pharma by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $132M | 3.3M | 40.37 |
| 2023-09-30 | $38M | 1.4M | 26.37 |
| 2023-06-30 | $18M | 1.0M | 17.20 |
| 2023-03-31 | $16M | 975k | 16.58 |
| 2022-12-31 | $10M | 1.4M | 7.62 |
| 2022-06-30 | $8.7M | 956k | 9.08 |
| 2022-03-31 | $7.3M | 723k | 10.15 |
| 2021-12-31 | $12M | 713k | 16.68 |
| 2021-09-30 | $29M | 619k | 46.87 |
| 2021-03-31 | $37M | 607k | 61.60 |
| 2020-12-31 | $45M | 627k | 71.11 |
| 2020-09-30 | $21M | 569k | 37.52 |
| 2020-06-30 | $12M | 374k | 32.61 |
| 2019-12-31 | $7.9M | 226k | 35.05 |
| 2019-09-30 | $3.7M | 171k | 21.47 |
| 2019-06-30 | $3.7M | 138k | 26.97 |